Myomo (MYO) Share-based Compensation (2016 - 2025)
Myomo (MYO) posted Share-based Compensation of $583991.0 for Q3 2025, up 47.89% on a QoQ basis from $394889.0 in Q2 2025, and up 80.14% year-over-year from $324185.0 in Q3 2024.
Myomo (MYO) Share-based Compensation (2016 - 2025) Analysis & Trends
Myomo's Share-based Compensation history runs 10 years deep, the most recent figure standing at $583991.0 for Q3 2025.
- Quarterly Share-based Compensation rose 80.14% year-over-year to $583991.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.8 million (up 233.15% YoY) and the FY2024 annual result came in at $874438.0, up 72.07% from the prior year.
- Share-based Compensation was $583991.0 for Q3 2025 at Myomo, up from $394889.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $583991.0 in Q3 2025 and bottomed at -$91893.0 in Q2 2024.
- A 5-year average of $305679.1 and a median of $320288.0 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation plunged 132.81% — and 2025, when it soared 529.73%.
- Myomo's Share-based Compensation stood at $301763.0 in 2021, then retreated by 9.41% to $273368.0 in 2022, then increased by 20.86% to $330394.0 in 2023, then dropped by 2.58% to $321858.0 in 2024, then jumped by 81.44% to $583991.0 in 2025.
- Business Quant data shows MYO's Share-based Compensation at $583991.0 in Q3 2025, $394889.0 in Q2 2025, and $540204.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 583,991.00 |
| Sep 30, 2025 | 583,991.00 |
| Jun 30, 2025 | 394,889.00 |
| Jun 30, 2025 | 394,889.00 |
| Mar 31, 2025 | 540,204.00 |
| Mar 31, 2025 | 540,204.00 |
| Dec 31, 2024 | 321,858.00 |
| Dec 31, 2024 | 321,858.00 |
| Sep 30, 2024 | 324,185.00 |
| Sep 30, 2024 | 324,185.00 |
| Jun 30, 2024 | -91,893.00 |
| Jun 30, 2024 | -91,893.00 |
| Mar 31, 2024 | 320,288.00 |
| Mar 31, 2024 | 320,288.00 |
| Sep 30, 2023 | 330,394.00 |
| Sep 30, 2023 | 330,394.00 |
| Jun 30, 2023 | 280,061.00 |
| Jun 30, 2023 | 280,061.00 |
| Mar 31, 2023 | 171,027.00 |
| Mar 31, 2023 | 171,027.00 |